Review



tissuescan complementary c dna microarray  (OriGene)


Bioz Verified Symbol OriGene is a verified supplier
Bioz Manufacturer Symbol OriGene manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    OriGene tissuescan complementary c dna microarray
    Tissuescan Complementary C Dna Microarray, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/complementary+dna+microarrays/TissueScan%2C+Thyroid+Cancer+cDNA+Array/10__1515_slash_oncologie___2025___0141-53-1-9
    Average 93 stars, based on 4 article reviews
    tissuescan complementary c dna microarray - by Bioz Stars, 2026-09
    93/100 stars

    Images

    Related Articles

    Microarray:

    Article Title: Enhanced annexin A2 expression with poor clinical parameters in papillary thyroid carcinoma
    Article Snippet: .. A TissueScan complementary (c)DNA microarray (HTRT101) was obtained from OriGene Technologies (USA), comprising five normal thyroid samples, and 43 thyroid cancer samples. .. Additionally, a thyroid cancer tissue array (CT1-L26) was purchased from Super Biochip (Seoul, Korea), which included nine normal thyroid, and 50 thyroid tumor samples at different stages and with different pathological features.

    Polymerase Chain Reaction:

    Article Title: WNT5A has anti-prostate cancer effects in vitro and reduces tumor growth in the skeleton in vivo.
    Article Snippet: .. Complementary DNA PCR array Prostate cancer cDNA Array III was purchased from Origene (Rockville, MD, USA) and assessed for WNT5A and FZD5 expression and normalized to b‐actin using the supplier’s protocol. ..

    Expressing:

    Article Title: WNT5A has anti-prostate cancer effects in vitro and reduces tumor growth in the skeleton in vivo.
    Article Snippet: .. Complementary DNA PCR array Prostate cancer cDNA Array III was purchased from Origene (Rockville, MD, USA) and assessed for WNT5A and FZD5 expression and normalized to b‐actin using the supplier’s protocol. ..

    Article Title: Phosphodiesterase SMPDL3B Gene Expression as Independent Outcome Prediction Marker in Localized Prostate Cancer
    Article Snippet: .. The expression of SMPDL3B was analyzed by qRT-PCR in a complementary deoxyribonucleic acid (cDNA) array (OriGene, Rockville, MD, USA; n = 40 PCa patients and n = 8 benign control samples, patient characteristics ) and a cohort of 55 patients who underwent radical prostatectomy (RP) in the Department of Urology and Urosurgery of the Mannheim Medical Center between 1998 and 2001 (patient characteristics in ). ..

    Quantitative RT-PCR:

    Article Title: Phosphodiesterase SMPDL3B Gene Expression as Independent Outcome Prediction Marker in Localized Prostate Cancer
    Article Snippet: .. The expression of SMPDL3B was analyzed by qRT-PCR in a complementary deoxyribonucleic acid (cDNA) array (OriGene, Rockville, MD, USA; n = 40 PCa patients and n = 8 benign control samples, patient characteristics ) and a cohort of 55 patients who underwent radical prostatectomy (RP) in the Department of Urology and Urosurgery of the Mannheim Medical Center between 1998 and 2001 (patient characteristics in ). ..

    Control:

    Article Title: Phosphodiesterase SMPDL3B Gene Expression as Independent Outcome Prediction Marker in Localized Prostate Cancer
    Article Snippet: .. The expression of SMPDL3B was analyzed by qRT-PCR in a complementary deoxyribonucleic acid (cDNA) array (OriGene, Rockville, MD, USA; n = 40 PCa patients and n = 8 benign control samples, patient characteristics ) and a cohort of 55 patients who underwent radical prostatectomy (RP) in the Department of Urology and Urosurgery of the Mannheim Medical Center between 1998 and 2001 (patient characteristics in ). ..

    Gene Expression:

    Article Title: ERBB4 is over-expressed in human colon cancer and enhances cellular transformation
    Article Snippet: .. Gene expression was confirmed by quantitative PCR on a second complementary DNA array data set (Origene) containing paired normal and tumor samples. ..

    Real-time Polymerase Chain Reaction:

    Article Title: ERBB4 is over-expressed in human colon cancer and enhances cellular transformation
    Article Snippet: .. Gene expression was confirmed by quantitative PCR on a second complementary DNA array data set (Origene) containing paired normal and tumor samples. ..

    DNA Array:

    Article Title: ERBB4 is over-expressed in human colon cancer and enhances cellular transformation
    Article Snippet: .. Gene expression was confirmed by quantitative PCR on a second complementary DNA array data set (Origene) containing paired normal and tumor samples. ..

    other:

    Article Title: High Fatty Acid-Binding Protein 4 Expression Associated with Favorable Clinical Characteristics and Prognosis in Papillary Thyroid Carcinoma.
    Article Snippet: Fatty acid-binding protein 4 (FABP4), a fatty acid transporter that coordinates lipid metabolism, is reported to exert a tumorigenic role in certain cancers.. We investigated the effects of FABP4 in the carcinogenesis of thyroid cancer.. Bioinformatics data about FABP4 in thyroid cancer were collected from the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA).

    Article Title: ZFP91 zinc finger protein expression pattern in normal tissues and cancers
    Article Snippet: Prostate cancer cDNA samples Cancer Survey cDNA Arrays I, II and III (CSRT101, CSRT103, CSRT104) from OriGene Technologies (Rockville, USA) were utilized providing 573 cDNA samples from a variety of human normal tissues and cancer types.

    Article Title: PLA2G7 associates with hormone receptor negativity in clinical breast cancer samples and regulates epithelial-mesenchymal transition in cultured breast cancer cells.
    Article Snippet: Invasion efficiency was determined as percentage of the relative wound confluence compared to respective negative control (regarded as 100%). cDNA tumour panel TissueScanTM Cancer Survey cDNA Array 96 – I (Origene, Rockville, MD, USA) consisting of 96 samples from 65 primary and 7 metastatic tumour samples as well as 24 non-malignant tissue samples derived from 8 different primary organs and provided with clinical information was utilised according to the manufacturer’s instructions to analyse the expression pattern of PLA2G7 mRNA in multiple malignancies.



    Similar Products

    90
    Agilent technologies complementary dna microarray
    Complementary Dna Microarray, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/complementary+dna+microarrays/pm26517400-59-9-10
    Average 90 stars, based on 1 article reviews
    complementary dna microarray - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    93
    OriGene tissuescan complementary c dna microarray
    Tissuescan Complementary C Dna Microarray, supplied by OriGene, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/complementary+dna+microarrays/TissueScan%2C+Thyroid+Cancer+cDNA+Array/10__1515_slash_oncologie___2025___0141-53-1-9
    Average 93 stars, based on 1 article reviews
    tissuescan complementary c dna microarray - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    OriGene tissuescan complementary (c)dna microarray
    Tissuescan Complementary (C)dna Microarray, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/complementary+dna+microarrays/tissuescan+complementary++c+dna+microarray/pm38884688-49-3-50
    Average 90 stars, based on 1 article reviews
    tissuescan complementary (c)dna microarray - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    MicroMax Inc complementary dna (cdna) microarray system
    Complementary Dna (Cdna) Microarray System, supplied by MicroMax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/complementary+dna+microarrays/cdna+microarray+system/pmc08246632-63-4-3
    Average 90 stars, based on 1 article reviews
    complementary dna (cdna) microarray system - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    99
    Thermo Fisher complementary dna microarray analysis hybridization
    Complementary Dna Microarray Analysis Hybridization, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/complementary+dna+microarrays/DNA/pm26411367-180-0-9
    Average 99 stars, based on 1 article reviews
    complementary dna microarray analysis hybridization - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    90
    Illumina Inc complementary dna microarray chip
    Complementary Dna Microarray Chip, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/complementary+dna+microarrays/complementary+dna+microarray+chip/pmc05545642-82-9-22
    Average 90 stars, based on 1 article reviews
    complementary dna microarray chip - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    99
    Thermo Fisher complementary dna microarray rna
    Complementary Dna Microarray Rna, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/complementary+dna+microarrays/DNA/pmc04565478-48-3-15
    Average 99 stars, based on 1 article reviews
    complementary dna microarray rna - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    90
    Illumina Inc complementary dna microarrays
    Complementary Dna Microarrays, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/complementary+dna+microarrays/complementary+dna+microarrays/pm24529500-45-7-6
    Average 90 stars, based on 1 article reviews
    complementary dna microarrays - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    99
    Thermo Fisher microarray slides complementary dna cdna
    Microarray Slides Complementary Dna Cdna, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/complementary+dna+microarrays/Deoxyribonucleic+acid/pm23065106-77-2-16
    Average 99 stars, based on 1 article reviews
    microarray slides complementary dna cdna - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    90
    Operon Biotech microarrays of complementary dna
    Protein expression levels of <t>DNA</t> repair proteins. Genes found to be altered in two gemtuzumab ozogamicin (GO)‐resistant subclones <t>(HL/GO,</t> <t>HL/GO‐CSA)</t> were evaluated for their protein expression levels by Western blotting.
    Microarrays Of Complementary Dna, supplied by Operon Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/complementary+dna+microarrays/microarrays+of+complementary+dna/pmc07659370-100-29-43
    Average 90 stars, based on 1 article reviews
    microarrays of complementary dna - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Protein expression levels of DNA repair proteins. Genes found to be altered in two gemtuzumab ozogamicin (GO)‐resistant subclones (HL/GO, HL/GO‐CSA) were evaluated for their protein expression levels by Western blotting.

    Journal: Cancer Science

    Article Title: Induction of DNA strand breaks is critical to predict the cytotoxicity of gemtuzumab ozogamicin against leukemic cells

    doi: 10.1111/j.1349-7006.2012.02343.x

    Figure Lengend Snippet: Protein expression levels of DNA repair proteins. Genes found to be altered in two gemtuzumab ozogamicin (GO)‐resistant subclones (HL/GO, HL/GO‐CSA) were evaluated for their protein expression levels by Western blotting.

    Article Snippet: The hybridization was carried out between Cy‐3‐labeled total RNA from the parental HL‐60 cells and Cy‐5‐labeled total RNA from the HL/GO cells or HL/GO‐CSA cells on microarrays of complementary DNA that contained 35 000 elements (Operon Aros, Human Genome Oligo Set, Version 4.0; Operon Biotechnologies, Tokyo, Japan).

    Techniques: Expressing, Western Blot

    Relationship between gemtuzumab ozogamicin (GO)‐associated parameters and GO sensitivity. (A) Tail moment values (number of DNA strand breaks) and IC 50 values were plotted within the same cell line (HL‐60, HL/GO, HL/GO‐CSA, HL/Ara‐CDNR, K562). The IC 50 values were determined using the XTT assay. Tail moment values were determined by the Comet assay after cells had been treated with 10 μg/mL GO for 6 h. The values are the means of triplicate determinations. (B–D) Similarly, the correlation between the IC 50 values and each of the factors (CD33 positivity, P‐glycoprotein [P‐gp] expression, and multridrug resistance protein‐1 [MRP1] mRNA) were evaluated. (E) Comparison was made between the CD33‐positive/P‐gp‐negative/MRP1‐negative cell lines (HL‐60, K562) and the others (HL/GO, HL/GO‐CSA, HL/ara‐CDNR). Bars represent the means.

    Journal: Cancer Science

    Article Title: Induction of DNA strand breaks is critical to predict the cytotoxicity of gemtuzumab ozogamicin against leukemic cells

    doi: 10.1111/j.1349-7006.2012.02343.x

    Figure Lengend Snippet: Relationship between gemtuzumab ozogamicin (GO)‐associated parameters and GO sensitivity. (A) Tail moment values (number of DNA strand breaks) and IC 50 values were plotted within the same cell line (HL‐60, HL/GO, HL/GO‐CSA, HL/Ara‐CDNR, K562). The IC 50 values were determined using the XTT assay. Tail moment values were determined by the Comet assay after cells had been treated with 10 μg/mL GO for 6 h. The values are the means of triplicate determinations. (B–D) Similarly, the correlation between the IC 50 values and each of the factors (CD33 positivity, P‐glycoprotein [P‐gp] expression, and multridrug resistance protein‐1 [MRP1] mRNA) were evaluated. (E) Comparison was made between the CD33‐positive/P‐gp‐negative/MRP1‐negative cell lines (HL‐60, K562) and the others (HL/GO, HL/GO‐CSA, HL/ara‐CDNR). Bars represent the means.

    Article Snippet: The hybridization was carried out between Cy‐3‐labeled total RNA from the parental HL‐60 cells and Cy‐5‐labeled total RNA from the HL/GO cells or HL/GO‐CSA cells on microarrays of complementary DNA that contained 35 000 elements (Operon Aros, Human Genome Oligo Set, Version 4.0; Operon Biotechnologies, Tokyo, Japan).

    Techniques: XTT Assay, Single Cell Gel Electrophoresis, Expressing, Comparison